Loading…

Human embryonic stem cell-derived cardiovascular progenitor cells stimulate cardiomyocyte cell cycle activity via activating the PI3K/Akt pathway

Promoting endogenous cardiomyocyte proliferation is crucial for repairing infarcted hearts. Implantation of human pluripotent stem cell-derived cardiovascular progenitor cells (hCVPCs) promotes healing of infarcted hearts. However, little is known regarding their impact on host cardiomyocyte prolife...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular and cellular cardiology 2024-12, Vol.197, p.5-10
Main Authors: Chen, Zhongyan, Yu, Xiujian, Ke, Minxia, Li, Hao, Jiang, Yun, Zhang, Peng, Tan, Jiliang, Cao, Nan, Yang, Huang-Tian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Promoting endogenous cardiomyocyte proliferation is crucial for repairing infarcted hearts. Implantation of human pluripotent stem cell-derived cardiovascular progenitor cells (hCVPCs) promotes healing of infarcted hearts. However, little is known regarding their impact on host cardiomyocyte proliferation. Here, we revealed that hCVPC implantation into mouse infarcted hearts induced dedifferentiation and cell cycle re-entry of host cardiomyocytes, which was further confirmed in vitro by hCVPC-conditioned medium. Mechanistically, the PI3K/Akt signaling pathway mediated hCVPC-induced cardiomyocyte cell cycle re-entry. The findings reveal the novel function of hCVPCs in triggering cardiomyocyte dedifferentiation and cell cycle activation and highlight a strategy utilizing cells at early developmental stages to rejuvenate adult cardiomyocytes. [Display omitted] •Implantation of hCVPCs induces dedifferentiation and cell cycle activity of cardiomyocytes in the infarcted hearts.•The secretome of hCVPCs induces dedifferentiation and cell cycle activity of adult cardiomyocytes.•hCVPCs induce cardiomyocyte cell cycle activation via PI3K/Akt signaling pathway.
ISSN:0022-2828
1095-8584
1095-8584
DOI:10.1016/j.yjmcc.2024.10.002